logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
F

Frank R. Lichtenberg

columbia university

44H指数
307论文数
1.0W被引数
收录论文 46
发表时间
logo
How much has growth of ‘reasonable and necessary’ medical treatments reduced US mortality?“合理且必要”医疗治疗的增长在多大程度上降低了美国死亡率？
errEconomics of Innovation and New Technology
IF2.6
err2026-04-27
err0
PREAI
errFrank R. Lichtenberg
err分享
err收藏
The relationship between changes in prescription drug sales and changes in mortality and hospital utilization in Denmark, 2005-20192005-2019年丹麦处方药销售变化与死亡率和医院利用率变化之间的关系
errExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
err2026-04-21
err0
PREAI
errLichtenberg, Frank R.
err分享
err收藏
Medicare-Covered Innovation and U.S. Disability, 1997-2019: Evidence from Healthcare Procedure Codes and Health Survey DataMedicare-Covered Innovation and U.S. Disability, 1997-2019: 基于医疗程序编码和健康调查数据的证据
errHealth Policy and Technology
IF3.7
err2025-10-21
err0
errOAAI
errFrank R. Lichtenberg; Y. Tony Yang
err分享
err收藏
The impact of biomedical innovation on cancer mortality in 37 countries, 2003-20172003-2017年37个国家生物医学创新对癌症死亡率的影响
errECONOMICS & HUMAN BIOLOGY
IF1.8
err2025-09-01
err0
PREAI
errLichtenberg, Frank R.
err分享
err收藏
Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study美国标签外和禁忌药物使用的患病率及其与健康的关系: 一项横断面研究
errJOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
IF2.5
err2025-03-06
err0
errOAAI
errBlankart, Katharina E.; Lichtenberg, Frank R.
err分享
err收藏
Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the US
errJOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
IF2.5
err2024-06-19
err0
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002-2019
errSSM-POPULATION HEALTH
IF3.1
err2023-12-01
err0
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
The Relationship Between Pharmaceutical Innovation and Cancer Mortality in Spain, From 1999 to 2016
errVALUE IN HEALTH
IF6
err2023-12-01
err0
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
The impact of biomedical innovation on the disability of elderly Medicare recipients, 2013-2019
errECONOMICS OF INNOVATION AND NEW TECHNOLOGY
IF2.6
err2023-03-15
err2
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
Effect on mortality of inclusion of drugs in Thailand?s National List of Essential Medicines, 2005-20162005-2016年泰国国家基本药物目录中药物对死亡率的影响
errhealth policy
IF3.7
err2023-03-01
err1
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
Are estimates of 'potential gains in life expectancy' potentially unreliable?
errPUBLIC HEALTH
IF3.2
err2020-12-01
err1
PREAI
errLichtenberg, F. R.
err分享
err收藏
The impact of pharmaceutical innovation on the burden of disease in Ireland, 2000-2015
errJOURNAL OF PUBLIC HEALTH
IF3.1
err2020-01-11
err1
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
The impact of pharmaceutical innovation on the burden of disease in Canada, 2000-2016
errSSM-POPULATION HEALTH
IF3.1
err2019-08-01
err8
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
The impact of access to prescription drugs on disability in eleven European countries
errDISABILITY AND HEALTH JOURNAL
IF3.3
err2019-07-01
err6
errOAAI
errLichtenberg, Frank R.
err分享
err收藏
The physician-patient relationship in the age of precision medicine
errGENETICS IN MEDICINE
IF6.2
err2019-04-01
err20
errOAAI
errEyal, Gil; Sabatello, Maya; Tabb, Kathryn; Adams, Rachel; Jones, Matthew; Lichtenberg, Frank R.; Nelson, Alondra; Ochsner, Kevin; Rowe, John; Stiles, Deborah; Sivaramakrishnan, Kavita; Underhill, Kristen; Appelbaum, Paul S.
err分享
err收藏
The long-run impact of new medical ideas on cancer survival and mortality
errECONOMICS OF INNOVATION AND NEW TECHNOLOGY
IF2.6
err2018-12-23
err4
PREAI
errLichtenberg, Frank R.
err分享
err收藏
The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination
errhealth policy
IF3.7
err2017-06-01
err0
PREAI
errLichtenberg, Frank R.; Tatar, Mehtap; Caliskan, Zafer
err分享
err收藏
HAS PHARMACEUTICAL INNOVATION INCREASED PERSISTENCE AND ADHERENCE OF MULTIPLE SCLEROSIS PATIENTS IN GERMANY?
errVALUE IN HEALTH
IF6
err2016-11-01
err0
errOAAI
errFischer, K. E.; Frey, S.; Lichtenberg, F.
err分享
err收藏
THE IMPACT OF PHARMACEUTICAL INOVATION ON PREMATURE CANCER MORTALITY IN PORTUGAL
errVALUE IN HEALTH
IF6
err2015-11-01
err0
errOAAI
errLichtenberg, F.; Laires, P. A.
err分享
err收藏
THE IMPACT OF PHARMACEUTICAL INNOVATION ON LONGEVITY IN PORTUGAL, 2002-2010
errVALUE IN HEALTH
IF6
err2015-11-01
err0
errOAAI
errLichtenberg, F.; Laires, P. A.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
Z
Zvi Griliches
H 指数: 103 · 论文数: 314
K
Kevin N. Ochsner
H 指数: 93 · 论文数: 315
B
Bengt Jönsson
H 指数: 84 · 论文数: 428
P
Paul S. Appelbaum
H 指数: 83 · 论文数: 1.1K
J
John W. Rowe
H 指数: 72 · 论文数: 329
查看更多